Showcasing revenue and compliance solutions at CBI Conference in New Jersey
Bridgewater, NJ – June 13, 2017 – iContracts, a leading provider of cloud-based contract, compliance and revenue management solutions today announced they are exhibiting at the 13th annual Commercial Contract and Chargeback Excellence Conference at the Hilton in Parsippany, New Jersey, June 21 – 22.
The annual CBI conference will focus on ways to improve the wholesaler chargeback process, navigate class of trade schema complexities, streamline membership management, and optimize contract administration and operations. This comprehensive forum will provide pharmaceutical and biotech professionals best practices and strategies to improve contract operations and considerably reduce revenue leakage for their organizations.
“We are excited to participate in this leading industry event again this year,” said Steve Johnson, Director of Sales at iContracts Inc. “The Commercial Contract and Chargeback Excellence Conference provides iContracts with the opportunity to network with pharmaceutical and biotech professionals who understand the need and benefits of our full suite of Commercial, Gross-To-Net and Government solutions as well as our ability to outsource all or part of these business processes on our customer’s behalf. We look forward to demonstrating firsthand how iContracts’ solutions are better, faster to implement, and far more cost effective for the life sciences market.”
Some of iContract’s key revenue management customers are participating as speakers during the event. Donna White, Vice President, Contracts and Compliance at Chiesi USA, will contribute to an interactive discussion, Benchmarking and Organizational Best Practices for Membership Efficiency. Sherice Koonce, Director of Contracts at West-Ward Pharmaceuticals, and Lisa Ellington, Senior Manager, Contract and Chargeback Operations at McKesson will be participating as panelists for the Enhance Communication to Facilitate Wholesaler, GPO and Manufacturer Alignment Panel. Additionally, Andrew Wilson, Vice President of 340B Solutions at McKesson will participate as a panelist on the 340B Program Update Panel.
During the two day event, iContracts will showcase their revenue and compliance management solutions and services. Participants of the conference can visit the iContracts exhibit to learn about their latest product innovations and meet members of the team.
iContracts’ suite of fully integrated software and outsourcing solutions manages all aspects of a company’s contracting processes, including, processing chargebacks, rebates, Medicaid rebates, Medicare GAP payments, other incentive agreements. Gross-To-Net and Government Pricing compliance at all levels. They also provide a flexible central repository for contracts of any type.
About iContracts
iContracts’ goal is simple – to deliver better solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Our software is generations ahead of other solutions, powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by learning just two simple, reusable views and backed by the most highly evolved data architecture in the industry – built by technologists with considerable and unique experience in building contract management solutions. This deep understanding and straightforward approach shows in everything we do. Our solutions are enterprise-class and can be quickly and easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers. For more information, please visit www.icontracts.com.
About CBI
Creating compelling content and personal connections for the Life Science industry for nearly two decades. CBI, an Advanstar company, is the life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device and healthcare industries. CBI’s proprietary and intensive market research and product feasibility testing methodology has helped CBI deliver timely and first to market content driven conferences.